Clinical Trial Update: A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States [Phase 1, Phase 2]

View source ↗

Summary

A safety study of two dapivirine vaginal gels (Phase 1/2) completed in the United States assessing safety in HIV-1 infection prevention context.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal gel (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV-1 Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-10-25